MorphoSys EUR 115 million Capital Increase, Germany

16 November 2016

To find out more, Contact STJ Advisors

STJ Advisors advised MorphoSys AG, the German biotechnology company involved in the development of research and antibodies, on their capital increase via an accelerated bookbuild offering, raising proceeds of EUR 115 million.

Back to Transactions

Expert advice to the most sophisticated issuers